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Abstract
Family history has considered as a risk factor of type 2 diabetes. Transcription factor-7 like 2 (TCF7L2) has 
role to regulates insulin secretion and blood glucose homeostasis. The aim of current study was to determine the 
rs7903146 polymorphism of TCF7L2 gene and homeostatic model assessment-β (HOMA-β) level on individual with 
and without type 2 Diabetes Mellitus (DM) family history. This work is a case-control study. Thirty six subjects 
with type 2 DM family history and 36 subjects without type 2 DM family history were recruited. HOMA-β 
measure to analyze the insulin secretion. Polymorphisms of TCF7L2 gene was analyzed by using PCR-RFLP 
method. Statistical analysis was performed by using T-test, Mann-Whitney and Chi-square with signifi cance 
level 0.05. The frequency of the T allele of the cases were 4.2% and the controls were 2.8% (p=0.500). The odd 
ratio was 0.649 (CI;95%:0.106-4.055). The HOMA-β levels of the cases were signifi cant low (132.56±62.48) 
compared with the controls (266.09±1.68) with p=0.000. The subjects with type 2 DM family history have a 
similar frequency of having T alleles and CT/TT genotypes. The subjects with type 2 DM family history has 
signifi cantly lower HOMA-β levels than subject without DM family history. 
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Introduction
Diabetes mellitus (DM) is a multi-
factorial disease which has a complex 
interaction between genetic and environment 
factors. Genetic factor is an important role to 
determine the incidence of familial diabetes 
(Bener et al., 2013). Erasmus et al. (2001) has 
reported that the incidence of type 2 diabetic 
was contributed by genetic role and family 
aggregation in some population.
Family history is considered as a risk 
factor in type 2 DM (Bener et al., 2013). 
Harrison et al. (2003) has shown that diagnosis 
of DM will be increase 2-4 fold if one or 
both parents was suffering from diabetes 
mellitus.
The Transcription Factor 7-like 2 
(TCF7L2) is a gene which contributed in 
the developing of type 2 DM. The TCF7L2 
gene has played a role to encoding the 
transcription factor which involved in 
Wingless-type mouse mammary tumor virus 
(MMTV) integration site family member 
(Wnt) of signal pathway (Lyssenko et al., 
2007). The Wnt signal has an important action 
to regulate several genes through TCF7L2 
activation, such as the expression of pro-
glucagon gene which encoding the insulin-
tropic hormone, glucagon-like peptide-1 
(GLP-1). The TCF7L2 activates pro-glucagon 
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gene expression lead to GLP-1 secretion (Tong 
et al., 2009). The glucagon-like peptide-1 has 
played a role in blood glucose homeostasis 
and elevates insulin secretion, so this could 
be explained that TCF7L2 has an indirect role 
as a regulation factor of insulin secretion and 
blood glucose homeostasis (Tong et al., 2009; 
Yu et al., 2009).
The rs7903146 (IVS3C/T) polymorphism 
contributed 10-25% in all of diabetes 
cases (Xavier et al., 2009). The rs7903146 
polymorphism of TCF7L2 gene has been 
related with type 2 diabetes which lead to 
impaired insulin secretion and elevated 
hepatic glucose production (Wegner et al., 
2008). 
A number of studies have demonstrated 
that individuals with type 2 DM family 
history has 2-fold risk to suffering from 
type 2 DM than individuals without type 2 
DM family history (Wicaksono, 2011). The 
genetic polymorphism of individuals with 
type 2 DM family history is interested to 
be investigated in Indonesian population. 
The aim of this study was to investigate 
the rs7903146 polymorphism of TCF7L2 
gene among individuals with and without 
type 2 DM family history in Indonesian 
population.
Materials and Methods
This study is a case-control study. 
The subject was divided into case and 
control groups. The case group consist 
of patient with type 2 DM family history 
was recruited from  outpatients clinic of 
Dr. Sardjito Hospital Yogyakarta.  The 
control group is subjects without type 2 
DM family history which was recruited 
from community in Yogyakarta. This study 
has been approyed by Medical and Health 
Research Ethics Committee, Faculty of 
Medicine, UGM.
Inclusion criteria of this study were 
healthy subjects, male or female at age 19-39 
years old, BMI ≤ 24 kg/m2 and signing the 
informed consent form. 
Blood chemical examination
Whole blood samples which obtained 
from the subjects after informed consent 
has been done. Glucose oxidase-p-amino 
phenazone (GOD-PAP) method was used 
for measuring blood glucose line. Insulin 
level was analyzed from blood serum by 
ELISA method (DRG® kit) to obtain the 
HOMA-β level. The HOMA-β was calculated 
to determine the function of pancreatic beta 
cell with the following below (Chen et al., 
2012; Oya et al., 2014):
DNA isolation
DNA was isolated using Wizard® 
Genomic DNA Purifi cation Kit (Promega). 
DNA was isolated from 400 μL leucocytes 
sample and was briefl y performed by mixed 
the 900 μL erythrocyte lyses buffer, 300 
μL nucleid lyses solution, 100 μL protein 
precipitation solution, 300 μL isopropanol, 
300 μL ethanol 70%, 100 μL DNA rehydration 
solution and incubate for 12 hour at 4ºC. 
Polymerase chain reaction (PCR)
Amplifi cation of DNA was performed 
by mixed the 15 μL PCR mix, 11 μL H2O, 2 μL 
DNA in a tube, then spin down for a minute 
at 3500 rpm. The primers (IDT, Inc) sequence 
for TCF7L2 gene segment amplifi cation were 
5’ - GAG AGC TAA GCA CTT TTT AGG 
TA - 3’ (forward) and 5’ - CTG ACA TTG 
ACT AAG TTA CTT GC - 3’ (reverse). PCR 
amplifi cation conditions were as follows: an 
initial denaturation at 95ºC for 15 minutes, 
followed by 35 cycles of denaturation at 95ºC 
for 30 seconds, annealing at 54ºC for 30 seconds, 
extension at 72ºC for 30 seconds, fi nal extension 
at 72ºC for 5 minutes and cooling at 4ºC. The 
PCR program was running for 1h 36 minutes.
Restriction fragment length polymorphism 
(RFLP)
The enzymatic digestion of PCR product 
was performed by mixed the 0.5 μL restriction 
enzyme Rsa1, 4.5 μL H2O, 1 μL tango buffer, 4 
μL DNA in a tube. The reaction mixture was 
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incubated for 16 hour at 37ºC. The C allele 
was represented by two fragments of 91 and 
22 base pairs and T allele was represented by 
one fragment of 113 base pair.
Electrophoresis
Electrophoresis analysis was performed 
by using the 3% of agarose with ethidium 
bromide (EtBr).
Statistical analysis
Statistical analysis was performed by 
using univariate (mean, SD) and bivariate 
(independent t-test, Mann-Whitney and Chi-
square) analysis.
Results
Subject Characteristic
We enrolled 72 subjects that consisted of 
36 individual with type 2 DM family history 
and 36 individual without type 2 DM family 
history. The age, body mass index (BMI), 
blood pressure (systolic blood pressure and 
diastolic blood pressure), and fasting blood 
glucose were not statistically difference 
between subjects with and without type 2 
DM family history (Table 1).
The rs7903146 polymorphism of TCF7L2 gene
The result of genotype analysis of 
rs7903146 polymorphism of TCF7L2 gene in 
this study was shown on Figure 1.
The frequency distribution of genotypes 
and alleles of rs7903146 polymorphism of 
TCF7L2 gene
The genotype and allele distribution 
of rs7903146 polymorphism of TCF7L2 
gene is shown in Table 2. The odds ratio 
(OR) and Hardy-Weinberg is also shown 
in Table 2.
Data are presented as mean ± SD. 
Distribution of data was analyzed by 
Shapiro-Wilk: p≥0.05. Independent t-test: 
p ≤ 0.05: signifi cantly difference. *Mann-
Whitney U test:  pć 0.05:significantly 
difference.
Table 1. Characteristic of subjects with and without  type 2 DM family history
Variable With  type 2 DM family history n = 36
Without  type 2 DM 
family history n = 36
p
(CI 95%)
Gender (M/F)
Age (year)
BMI (kg/m2)
Blood pressure (mmHg) 
Sistole
Diastole
Fasting Blood Glucose (mg/dL)
9/27
23,64±3,66
20,45±2,15
109,50±9,44
72,08±7,18
90,64±12,55
9/27
24,19±3,50
20,51±1,87
109,33±8,24
73,17±7,93
89,61±9,87
1,00
(0,34-2,90)
0,37*
0,90
(-1,01-0,89)
0,93
(-4,00-4,33)
0,54
(-4,64-2,47)
0,70
(-4,28-6,33)
 
 
 
 
 
113bp
91bp 
100 
M   CC CC CT CC  CT CC CC 
Figure 1.  The genotyping result of rs7903146 
polymorphism of TCF7L2 gene. M = Marker. CC 
genotype = wild-type (91 bp and 22 bp), CT genotype 
= variant (113 bp and 91 bp).
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The difference mean of Insulin and HOMA-β 
levels 
The mean of insulin and HOMA-β 
levels of subjects with type 2 DM family 
history was signifi cantly lower than subjects 
without type 2 DM family history (p=0.00) 
(Table 3).
The association of CC and CT genotypes 
of TCF7L2 gene with insulin and HOMA-β 
levels
Statistically, the mean of insulin and 
HOMA-β levels in CC and CT genotypes 
was not signifi cantly different between two 
groups (Table 4 and 5). 
Table 2. The distribution of genotype (TT, CT, and CC) and allele (T and C) of TCF7L2 gene among 
subjects with and without  type 2 DM family history
Variable
With  type 2 
DM family history 
n = 36
Without type 2 DM 
family history 
n = 36
OR p H-W
Genotype CC
CT
TT
33 (91.7%)
3 (8.3%)
0 (0%)
34(94.4%)
2(5.6%)
0(0%)
0.647 0.500
1.000
Allele C
T
69(95.8%)
3(4.2%)
70(97.2%)
2(2.8%)
0.657 0.500
The Pearson Chi-square-Fishers Exact Test: p< 0,05: signifi cantly difference. H-W= Hardy-Weinberg 
Equilibrium.
Table 3. The difference means of insulin and HOMA-β levels between subject with and without family 
history of type 2 DM
Variable
With family history 
DM 
n = 36
Without family 
history DM 
n = 36
p
Insulin (μIU/mL) 9.77±6.35 16.18±3.76 0.00
HOMA-β (%) 132.56±62.48 266.09±1.68 0.00
Data are expressed as mean±SD. Independent T-test: p ≤ 0,05. *Mann-Whitney U test: p ≤ 0,05.
Table 5. The difference means of HOMA-β on CC and CT genotypes among subjects with and without 
type 2 diabetes family history 
Variable With type 2 DM family history p
Without type 2 DM family 
history p
CC
(n = 33)
CT
(n = 3)
CC
(n = 34)
CT
(n = 2)
HOMA-β (%) 130.5±59.6 154.3±1.03 0.53 244.9±1.12 626.1±5.51 0.30
Data are presented as mean±SD. Mann-Whitney U test: p ≤ 0,05.
Table 4. The difference means of insulin level on CT and TT genotypes among subject with and without 
type 2 DM family history
Variable With type 2 DM 
family history 
P Without type 2 DM 
family history 
p
CC
(n = 33)
CT
(n = 3)
CC
(n = 34)
CT
(n = 2)
Insulin level
(μIU/mL) 9.1±5.3 16.8±12.9 0.40* 16.2±3,8 14.6±0,7 0.54
Data are described as mean±SD. Independent T-test: p ≤ 0,05. *Mann-Whitney U test: p ≤ 0,05.
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Discussion
Family history is important in the 
clinical setting and patient’s management, 
such as modifi cation of environmental factors 
or lifestyle, increasing diagnosis accuracy, and 
prevention of expensive medical expenses 
(Das et al., 2012). A type 2 DM family history 
may be associated with insulin resistance and 
dysfunction of pancreatic β-cells (Arslanian et 
al., 2005). Danadian et al. (1999) showed that 
individuals with type 2 DM family history 
leads to decrease the insulin sensitivity by 
25%.
Rs7903146 polymorphism of TCF7L2 
gene plays a role in the pathogenesis of 
type 2 DM which affects the regulation 
of transcription in insulinothropic GLP-1 
hormone thereby reducing the secretion 
of insulin and improve glucose hepatic 
production. Single nucleotide polymorphism 
(SNP) rs7903146 in intron 3 is a C allele 
transformation into T allele. The T allele 
in TCF7L2 gene associated with insulin 
secretion interference and insulin sensitivity 
enhancement (Alibegovic et al., 2010). 
Lyssenko et al. (2007) observed that the CT/
TT genotype was strongly associated with 
type 2 DM. The T allele is also associated 
with insulin secretion interference, increasing 
glucose production. In addition, T allele has 
a larger role in open chromatin and activity 
enhancement compared to C allele (Gaulton 
et al., 2010). The dysfunction of beta cells is 
caused by protein TCF7L2 defi ciency and 
post-trancription TCF7L2 disorders. The basic 
mechanism that explains the regulation of 
transcription and translation of TCF7L2 was 
still unclear (Shu et al., 2009). The depletion 
of TCF7L2 caused a five-fold increase in 
β-cell apoptosis, a two-fold decline in β-cell 
proliferation and a two-fold decrease in 
insulin secretion (Shu et al. (2008).
The subjects enrolled in this study 
were in normal condition. All subjects blood 
glucose level was ≤ 126 mg/dL, mean of level 
of body mass index (BMI) of two groups were 
20 kg/m2, and subjects blood pressure was 
≤ 140/90 mmHg. This result was associated 
with subject characteristic which healthy 
subject. The PERKENI was reported that 
diagnose of diabetes was established if 
fasting blood glucose level ≥126 mg/dL 
(7.0 mmol/L), not obesity (≤ 25 kg/m2) and 
normal blood pressure (≤ 140/90 mmHg) 
(PERKENI, 2011; Annurad et al., 2003).
This study found only two genotypes in 
each group, there are wild type homozygote 
genotype (CC) and variant heterozygote 
genotype (CT). This result was different with 
previous study that found TT, TC, and CC 
genotypes at Japanese (Miyake et al., 2007), 
Indian population (Jyothi et al., 2013), Chinese 
population (Wang et al., 2013) and Brazilian 
population (Marquizine et al., 2008).
The frequency distribution of CC 
genotype was higher than CT genotype. 
However, it was not statistically different 
between subjects with and without type 2 DM 
family history (p=0.500). Alsmadi et al. (2008) 
reported that the frequency of genotype 
and allele of rs7903146 polymorphism 
at Arab population was not statistically 
different between case and control subjects 
(p=0.573 and p=0.675), respectively. This 
result was different with previous study at 
Dutch Breda population. Vliet et al. (2007) 
reported that there was signifi cantly different 
(p=0.009 and p=0.00004, respectively). The 
frequency of genotype and allele of rs7903146 
polymorphism in Amish population also 
reported a similar results (p=0.008) by 
Damcot et al. (2006).
The polymorphism is affected by 
geographical and ethnical differences, so it 
causes genotype frequency differences. The 
TCF7L2 gene genotype frequencies showed 
variations geographically and ethnically. The 
population of French, Dutch, Afro-American, 
and Mexico have a high TCF7L2 gene rs7903146 
genotype frequency (Goodarzi et al., 2007; 
Bodhini et al., 2007; Moczulski et al., 2007).
In this study, the genotype distribution 
of the rs7903146 polymorphism of TCF7L2 
gene was not diverge from Hardy-Weinberg 
equilibrium (p=1.000). It can be concluded 
that genotype and allele frequencies at 
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this population were distributed normally. 
Individual with type 2 DM family history 
have a low frequency of  T allele and CT/TT 
genotypes. The same results were reported 
at Arabian population (Alsmadi et al., 2008) 
and Indian Pima population (Guo et al., 
2007) that rs7903146 has low risk to type 2 
DM (OR=1.04). In another study conducted 
in France population (Moczulski et al., 2007) 
and Italian population (Gambino et al., 2010) 
were reported different result that rs7903146 
was a risk factor of type 2 DM.
The mean of insulin levels was lower 
among subjects with type 2 DM family 
history than subjects without type 2 DM 
family history (p=0.00). Chen et al. (2012) 
and Arslanian et al. (2005) also found that 
insulin level of subject with type 2 DM family 
history was lower than subjects without type 
2 DM family history. The low insulin level 
on subjects with type 2 DM family history 
indicates that there was a decreasing insulin 
secretion due to abnormality of pancreatic 
β-cell (Arslanian et al., 2005).
HOMA-β was employed for evaluation 
of pancreatic β-cell (Chen et al., 2012). 
HOMA-β values were parallel with the 
results of insulin levels, which is signifi cantly 
lower in subjects with a type 2 DM family 
history than in subjects without a type 2 DM 
family history. Chen et al. (2012) was shown 
that individuals with type 2 DM family 
history has impaired function of pancreatic 
β-cell with low HOMA-β level compared 
with HOMA-β level of subjects without 
type 2 DM family history. The decreasing 
of insulin secretion resulted from impaired 
function of pancreatic β-cell which caused 
by several factor, include genetic factors 
(DeFronzo et al., 2008).
In this study, the number of samples 
that have been enrolled is much lower than 
in the other study. Insuffi cient number of 
samples caused TT genotype could not be 
found in this study. Certainly, a limitation 
of this study.
Conclusion
The polymorphism of TCF7L2 gene is 
not risk of individuals with and without type 2 
DM family history in Indonesian population. 
The Insulin secretion on individuals with 
type 2 DM family history was lower than 
that of individuals without type 2 DM family 
history. 
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